does tirzepatide or semaglutide have less side effects vs for Weight Loss Tirzepatide vs Semaglutide: A Comprehensive

Dietary recommendations for the management of gastrointestinal symptoms in patients treated with GLP-1 receptor agonists

The selection and handover of the development candidate will provide milestone payments of $4 million to Gubra

It also helps the body get rid of harmful wastes

From a safety standpoint, retatrutide's known adverse effect profile from phase II trials includes: Nausea, vomiting, and diarrhoea (gastrointestinal effects common to GLP-1 receptor agonists) Reduced appetite and potential nutritional deficiencies with prolonged use Elevated heart rate observed in some trial participants Pancreatitis and gallbladder disease , which are recognised class cautions for GLP-1based therapies and should be considered in the context of retatrutide, although retatrutide-specific data remain limited Thyroid C-cell changes , observed in rodent studies with GLP-1 receptor agonists

Instead, it works gradually, helping your body feel full sooner, think about food less often, and feel satisfied with smaller portions